Sustained release formulation of nalbuphine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9186330
APP PUB NO 20140315937A1
SERIAL NO

14319833

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ENDO OPERATIONS LIMITEDBALLSBRIDGE DUBLIN 4

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baichwal, Anand R Wappingers Falls, US 70 2087
Carpanzano, Anthony E New Milford, US 14 599
Diehl,, II Donald New Fairfield, US 6 14
Goliber, Philip A Lasne, BE 10 125
Sciascia, Thomas Belmont, US 31 76
Vogler, Brian North White Plains, US 9 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00